NO993709L - Stabilisert blanding omfattende fibrinogen - Google Patents

Stabilisert blanding omfattende fibrinogen

Info

Publication number
NO993709L
NO993709L NO993709A NO993709A NO993709L NO 993709 L NO993709 L NO 993709L NO 993709 A NO993709 A NO 993709A NO 993709 A NO993709 A NO 993709A NO 993709 L NO993709 L NO 993709L
Authority
NO
Norway
Prior art keywords
fibrinogen
solution
arginine
lysine
stabilized composition
Prior art date
Application number
NO993709A
Other languages
English (en)
Other versions
NO993709D0 (no
Inventor
Israel Nur
Lilliana Bar
Oded Lieberman
Original Assignee
Omrix Biopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP97101569A external-priority patent/EP0856317A1/en
Application filed by Omrix Biopharm Sa filed Critical Omrix Biopharm Sa
Publication of NO993709D0 publication Critical patent/NO993709D0/no
Publication of NO993709L publication Critical patent/NO993709L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Det beskrives en stabilisert løsning av fibrinogenholdige prøver, særlig en stabilisert løsning av den biologisk aktive komponent (BAC) som er en løsning av proteiner som skriver seg fra blodplasma omfattende fibrinogen, tranexamsyre, samt arginin eller lysin eller blandinger av arginin og lysin, deres farmasøytisk akseptable salter, og eventuelt substanser som danner en buffret løsning i et vandig medium.
NO993709A 1997-01-31 1999-07-30 Stabilisert blanding omfattende fibrinogen NO993709L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97101569A EP0856317A1 (en) 1997-01-31 1997-01-31 A stabilized mixture comprising fibrinogen
PCT/EP1998/000502 WO1998033533A1 (en) 1997-01-31 1998-01-30 A stabilized mixture comprising fibrinogen

Publications (2)

Publication Number Publication Date
NO993709D0 NO993709D0 (no) 1999-07-30
NO993709L true NO993709L (no) 1999-09-28

Family

ID=8226433

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993709A NO993709L (no) 1997-01-31 1999-07-30 Stabilisert blanding omfattende fibrinogen

Country Status (13)

Country Link
US (1) US6121232A (no)
JP (1) JP3825055B2 (no)
KR (1) KR100345570B1 (no)
CN (1) CN1182879C (no)
AT (1) ATE218365T1 (no)
AU (1) AU724715B2 (no)
BR (1) BR9807043A (no)
CA (1) CA2279419A1 (no)
DE (1) DE69805772T2 (no)
ES (1) ES2178153T3 (no)
HU (1) HUP0000908A3 (no)
NO (1) NO993709L (no)
PL (1) PL194316B1 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
US7276235B2 (en) * 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
CN100345591C (zh) * 2003-08-01 2007-10-31 上海新兴医药股份有限公司 耐干热处理的速溶冻干纤维蛋白原制剂
US7186684B2 (en) * 2003-08-07 2007-03-06 Ethicon, Inc. Hemostatic device containing a protein precipitate
ES2530989T3 (es) * 2004-10-20 2015-03-09 Ethicon Inc Hemostático absorbible
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
CA2682173C (en) * 2007-03-22 2015-10-27 Km Biologics Co., Ltd. Solid fibrinogen preparation
EP2011524A1 (en) * 2007-07-02 2009-01-07 Omrix Biopharmaceuticals Ltd. Fibrin glue with a visualization agent
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
US10039865B2 (en) * 2008-09-22 2018-08-07 Omrix Biopharmaceuticals Ltd. Implantable device comprising a substrate pre-coated with stabilized fibrin
JP5805542B2 (ja) * 2009-02-20 2015-11-04 オムリックス・バイオファーマシューティカルズ・リミテッドＯｍｒｉｘ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． 少なくとも２成分の薬物を投与する装置
ES2513516T3 (es) 2010-01-28 2014-10-27 Omrix Biopharmaceuticals Ltd. Método para un sellado con fibrina mejorado
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
CA2811493C (en) * 2010-09-15 2020-06-16 Debiopharm International Sa Method for separating target molecules or particles from fibrinogen-containing samples including blood components
EP2624823A4 (en) 2010-09-23 2016-08-03 Inflammagen ADMINISTRATION OF SERIN PROTEASE INHIBITORS IN THE STOMACH
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
IL213375A0 (en) 2011-06-05 2011-07-31 Omrix Biopharmaceuticals Device for spraying fluids in proximity to a surface
WO2013151725A1 (en) 2012-04-05 2013-10-10 The Regents Of The University Of California Regenerative sera cells and mesenchymal stem cells
US10130346B2 (en) 2012-07-24 2018-11-20 Omrix Biopharmaceuticals Ltd. Device and method for the application of a curable fluid composition to a bodily organ
EP2934603A1 (en) 2012-12-20 2015-10-28 Omrix Biopharmaceuticals Ltd. Viral inactivated biological mixture
AU2013368867B2 (en) 2012-12-30 2018-02-01 Omrix Biopharmaceuticals Ltd. Device and method for the application of a curable fluid composition to a portion of a bodily organ
USD754325S1 (en) 2013-06-06 2016-04-19 Omrix Biopharmaceuticals Ltd. Device of a curable fluid composition to a bodily organ
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing zymogens
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
CA2942358C (en) 2014-03-25 2023-03-28 Leading BioSciences, Inc. Compositions for the treatment of autodigestion
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
IL234246A0 (en) 2014-08-21 2014-11-30 Omrix Biopharmaceuticals Ltd Stabilized thrombin
WO2016079727A1 (en) 2014-11-18 2016-05-26 Omrix Biopharmaceuticals Ltd. Spray-drying apparatus and method of use
IL235751A0 (en) 2014-11-18 2015-02-26 Omrix Biopharmaceuticals Ltd An addition to the spray dryer
JP6713479B2 (ja) 2015-02-25 2020-06-24 オムリックス・バイオファーマシューティカルズ・リミテッドＯｍｒｉｘ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． トロンビン及びその分解ポリペプチドの精製及び定量化方法
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
US10159720B2 (en) 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
IL242924A0 (en) 2015-12-03 2016-04-21 Omrix Biopharmaceuticals Ltd Syringe system for storing and mixing two ingredients
CA3010986A1 (en) 2016-01-11 2017-07-20 Leading BioSciences, Inc. Compositions and methods for treating and preventing adhesions and ileus
JP2017176713A (ja) * 2016-03-31 2017-10-05 テルモ株式会社 塗布具
IL247821A0 (en) * 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use
CN109081789B (zh) * 2017-06-13 2021-01-01 首都医科大学 氨基正己酰氨基甲环酰氨基正己酰脂肪氨基酸，其合成，活性和应用
IL261190A (en) 2018-08-16 2019-01-31 Omrix Biopharmaceuticals Ltd Stable liquid preparations of thrombin
IL263679A (en) * 2018-12-12 2019-03-31 Omrix Biopharmaceuticals Ltd Kits, methods, and compositions for preventing tissue adhesion
WO2020121290A1 (en) 2018-12-12 2020-06-18 Omrix Biopharmaceuticals Ltd. High concentrated protein compositions for preventing tissue adhesion
EP4401801B1 (en) 2021-09-16 2026-02-18 Ethicon, Inc. Kit for composition for tissue tract sealing
WO2023119277A1 (en) 2021-12-21 2023-06-29 Omrix Biopharmaceuticals Ltd. Highly soluble fibrinogen compositions
US20250108142A1 (en) 2023-09-28 2025-04-03 Ethicon, Inc. Methods for treating leakage from a gastrointestinal site

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
US5278189A (en) * 1990-06-04 1994-01-11 Rath Matthias W Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A)
DK0691858T3 (da) * 1993-03-30 2000-05-08 Omrix Biopharm Sa Tokomponent fibrinklæber

Also Published As

Publication number Publication date
JP3825055B2 (ja) 2006-09-20
DE69805772D1 (de) 2002-07-11
KR100345570B1 (ko) 2002-07-26
NO993709D0 (no) 1999-07-30
AU724715B2 (en) 2000-09-28
KR20000070634A (ko) 2000-11-25
HUP0000908A2 (hu) 2000-08-28
PL194316B1 (pl) 2007-05-31
BR9807043A (pt) 2000-03-28
ES2178153T3 (es) 2002-12-16
CN1246069A (zh) 2000-03-01
CA2279419A1 (en) 1998-08-06
AU6214598A (en) 1998-08-25
DE69805772T2 (de) 2003-01-30
PL334547A1 (en) 2000-03-13
US6121232A (en) 2000-09-19
HUP0000908A3 (en) 2001-05-28
ATE218365T1 (de) 2002-06-15
JP2000509630A (ja) 2000-08-02
CN1182879C (zh) 2005-01-05

Similar Documents

Publication Publication Date Title
NO993709D0 (no) Stabilisert blanding omfattende fibrinogen
DK1394179T3 (da) Fremgangsmåde til fremstilling af erythropoietin fri for animalske proteiner
KR920019371A (ko) 안정화된 인자 ⅷ 제제
BR9610511B1 (pt) construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica.
ATE248150T1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
CA2034489A1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
IL143670A0 (en) Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same
ATE205090T1 (de) Eine glucagon enthaltende pharmazeutische zubereitung
ATA29997A (de) Verfahren zur inaktivierung von lipidumhüllten viren
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
ATE265409T1 (de) Von aminosauren und hydroxysauren substituierte benzamidinderivate und deren verwendung als antikoagulantien
DE69715414D1 (de) Stabilisierte pharmazeutische zusammensetzung von bdnf
DE69023648D1 (de) Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung.
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
ATE272436T1 (de) Mikrofiltration unter verwendung von aktivkohle
ATE262315T1 (de) Stabilisiertes wässriges flüssiges blutgerinnungsfaktor xiii-präparat
ATE373083T1 (de) Methode und zusammensetzungen zur identifizierung von morphogen-analogen
DK165411C (da) Fremgangsmaade til oploesning af peptider, anvendelse deraf og ikke-vandige oploesninger indeholdende peptid/crown-ether complexer
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
DK0935652T3 (da) Keratinocyt vækstfaktor-2 produkter
AR004224A1 (es) Procedimiento para la inactivacion de virus en soluciones de proteinas
ATE149354T1 (de) Pharmazeutische zusammensetzung von stabilisiertem (leu 13>-motilin-hse
FI102541B1 (fi) Uudet glukoosi-isomeraasientsyymit ja niiden käyttö
NO963806L (no) Rekombinante viruser som koder for en glutamat-dekarboksylase (GAD)aktivitet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application